Try our beta test site
55 studies found for:    Open Studies | "Thalassemia"
Show Display Options
Rank Status Study
21 Recruiting The Effective and Safety of Thalidomide in NTDT
Condition: Thalassemia
Intervention: Drug: Thalidomide
22 Recruiting Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
Conditions: Sickle Cell Disease;   Thalassemia;   Stem Cell Transplantation;   Graft vs Host Disease
Interventions: Drug: Alemtuzumab;   Drug: Sirolimus;   Drug: Cyclophosphamide;   Drug: Pentostatin;   Drug: Radiotherapy
23 Recruiting Pilot Study Evaluating Safety & Efficacy of a DCBT: NiCord® & UNM CBU to SCD Patients After Myeloablative Therapy
Condition: Sickle Cell Disease & Thalassemia
Intervention: Drug: NiCord
24 Recruiting Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major
Condition: AL-Hijama in Thalassmia Major
Interventions: Procedure: Al-hijamah;   Drug: Deferasirox
25 Not yet recruiting In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)
Conditions: Alpha Thalassemia Major;   Hemoglobinopathy; With Thalassemia;   Hemoglobinopathies;   Fetal Anemia;   Fetal Hydrops;   Alpha; Thalassemia;   Thalassemia Major;   Thalassemia Alpha;   A-Thalassemia
Intervention: Biological: in utero hematopoietic stem cell transplantation
26 Recruiting Use of Mobile Technology for Intensive Training in Medication Management
Conditions: Sickle Cell Disease;   Thalassemia
Interventions: Behavioral: Video recording;   Behavioral: Medication Administration Log;   Behavioral: Education
27 Recruiting Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell Patients
Condition: Major Sickle Cell Syndrome of Type SS or Sβ Thalassemia
Intervention: Drug: Plerixafor
28 Recruiting QST-Pupillometry in Sickle Cell Disease Patients
Condition: SCD With Severe Phenotype (HbSS, HbSβ0 Thalassemia, HbSOARab)
Intervention: Other: Quantitative sensory testing
29 Recruiting Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
Condition: Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
Interventions: Drug: Montelukast added to Hydroxyurea;   Drug: Placebo added to Hydroxyurea
30 Recruiting Bone Marrow for Hemoglobinopathy Research
Conditions: Sickle Cell Anemia;   Thalassemia
Intervention:
31 Recruiting Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies
Conditions: Sickle Cell Disease;   Thalassemia
Intervention: Biological: CordIn
32 Recruiting B-Thalasaemia Trait and Its Possible Cardioprotective Role
Conditions: Beta-Thalassemia Trait;   Coronary Artery Disease
Intervention:
33 Recruiting HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
Conditions: Sickle Cell Disease;   Beta Thalassemia-Major
Interventions: Drug: alemtuzumab (Campath IH);   Drug: Fludarabine;   Drug: Melphalan;   Drug: Cyclosporine;   Drug: Mycophenolate mofetil;   Drug: Tacrolimus;   Biological: Hematopoietic Stem Cell Transplantation
34 Recruiting A Study of IMR-687 in Healthy Adult Volunteers
Conditions: Sickle Cell Disease;   Sickle-Cell; Hb-SC;   Sickle Beta 0 Thalassemia
Interventions: Drug: IMR-687;   Drug: Placebo Oral Capsule
35 Recruiting Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
Conditions: Sickle Cell Anemia;   Sickle Cell β+ or β0 Thalassemia
Intervention:
36 Recruiting Fetal Hemoglobin Induction Treatment Metformin
Conditions: Sickle Cell Anemia;   Sickle Cell Disease;   Hemoglobin Disorder;   Hemoglobin Disease; Sickle-Cell, Thalassemia
Intervention: Drug: Metformin
37 Recruiting Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
Conditions: Congenital Hemolytic Anemia;   Diamond-Blackfan Anemia
Interventions: Procedure: Radiotherapy;   Drug: Alemtuzumab (Campath );   Drug: Sirolimus (Rapamune )
38 Recruiting CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Conditions: Bone Marrow Failure Syndrome;   Severe Aplastic Anemia;   Severe Congenital Neutropenia;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Schwachman Diamond Syndrome;   Primary Immunodeficiency Syndromes;   Acquired Immunodeficiency Syndromes;   Histiocytic Syndrome;   Familial Hemophagocytic Lymphocytosis;   Lymphohistiocytosis;   Macrophage Activation Syndrome;   Langerhans Cell Histiocytosis (LCH);   Hemoglobinopathies;   Sickle Cell Disease;   Sickle Cell-beta-thalassemia
Intervention: Biological: CD34 Stem Cell Selection Therapy
39 Recruiting CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
Conditions: Leukemia;   Lymphoma;   Bone Marrow Failure;   Immunodeficiencies;   Histiocytosis;   Sickle Cell Disease;   Beta Thalassemia;   Inborn Errors of Metabolism
Interventions: Drug: Full Intensity with TBI;   Drug: Full Intensity;   Drug: Reduced Intensity;   Drug: Reduced Intensity (Fanconi)
40 Recruiting BMT Abatacept for Non-Malignant Diseases
Conditions: Hurler Syndrome;   Fanconi Anemia;   Glanzmann Thrombasthenia;   Wiskott-Aldrich Syndrome;   Chronic Granulomatous Disease;   Severe Congenital Neutropenia;   Leukocyte Adhesion Deficiency;   Shwachman-Diamond Syndrome;   Diamond-Blackfan Anemia;   Dyskeratosis-congenita;   Chediak-Higashi Syndrome;   Severe Aplastic Anemia;   Thalassemia Major;   Hemophagocytic Lymphohistiocytosis;   Sickle Cell Disease
Intervention: Drug: Abatacept

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-55) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.